These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15618202)

  • 61. Hemolytic uremic syndrome.
    Elliott EJ; Robins-Browne RM
    Curr Probl Pediatr Adolesc Health Care; 2005 Sep; 35(8):310-30. PubMed ID: 16126151
    [No Abstract]   [Full Text] [Related]  

  • 62. [Hemolytic uremic syndrome].
    Rota S; Cravedi P; Remuzzi G; Ruggenenti P
    G Ital Nefrol; 2005; 22 Suppl 33():S57-64. PubMed ID: 16419008
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome.
    Gomez SA; Abrey-Recalde MJ; Panek CA; Ferrarotti NF; Repetto MG; Mejías MP; Fernández GC; Vanzulli S; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2013 Sep; 173(3):463-72. PubMed ID: 23607458
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DNA sequence of the Escherichia coli O103 O antigen gene cluster and detection of enterohemorrhagic E. coli O103 by PCR amplification of the wzx and wzy genes.
    Fratamico PM; DebRoy C; Strobaugh TP; Chen CY
    Can J Microbiol; 2005 Jun; 51(6):515-22. PubMed ID: 16121232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Searching for a valid animal model of hemolytic uremic syndrome.
    Laszik ZG; Blakey GL
    Am J Clin Pathol; 2002 Sep; 118(3):323-5. PubMed ID: 12219773
    [No Abstract]   [Full Text] [Related]  

  • 66. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
    Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
    Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity.
    Shimizu T; Sato T; Kawakami S; Ohta T; Noda M; Hamabata T
    Microb Pathog; 2007; 43(2-3):88-95. PubMed ID: 17532600
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Attaching-effacing lesions associated with Escherichia coli O157:H7 and other bacteria in experimentally infected conventional neonatal goats.
    Wales AD; Pearson GR; Roe JM; Hayes CM; La Ragione RM; Woodward MJ
    J Comp Pathol; 2005; 132(2-3):185-94. PubMed ID: 15737345
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Shiga toxin-producing Escherichia coli: an overview.
    Gyles CL
    J Anim Sci; 2007 Mar; 85(13 Suppl):E45-62. PubMed ID: 17085726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
    Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
    Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases.
    Barrett TJ; Potter ME; Wachsmuth IK
    J Infect Dis; 1989 Apr; 159(4):774-7. PubMed ID: 2647865
    [No Abstract]   [Full Text] [Related]  

  • 72. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen.
    Mellmann A; Bielaszewska M; Zimmerhackl LB; Prager R; Harmsen D; Tschäpe H; Karch H
    Clin Infect Dis; 2005 Sep; 41(6):785-92. PubMed ID: 16107974
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Toxigenic Escherichia coli in haemolytic-uraemic syndrome.
    Pryor W; Hodson E; McIntyre P; Bettelheim KA
    Med J Aust; 1990 Feb; 152(4):221-2. PubMed ID: 2405245
    [No Abstract]   [Full Text] [Related]  

  • 74. More on hemolytic uremic-like syndrome.
    Martin ML; Shipman LD
    J Am Vet Med Assoc; 1988 Jun; 192(11):1493-4. PubMed ID: 3045058
    [No Abstract]   [Full Text] [Related]  

  • 75. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
    Louise CB; Kaye SA; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1995 Jul; 63(7):2766-9. PubMed ID: 7790096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells.
    Obrig TG; Seaner RM; Bentz M; Lingwood CA; Boyd B; Smith A; Narrow W
    Infect Immun; 2003 Feb; 71(2):845-9. PubMed ID: 12540565
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of an experimental hemolytic uremic syndrome in rats.
    Zotta E; Lago N; Ochoa F; Repetto HA; Ibarra C
    Pediatr Nephrol; 2008 Apr; 23(4):559-67. PubMed ID: 18253762
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
    Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
    Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 50 Years Ago in TheJournal ofPediatrics: The Hemolytic-Uremic Syndrome in Nonrelated Adopted Siblings.
    Herrada AM; Toltzis P
    J Pediatr; 2019 Dec; 215():151. PubMed ID: 31761137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.